Program

92
90
5
3
2
1

Journal Year Published

16
11
20
10
8
9
10
12
12
10
12
4

Author

134
183
175
135
127
119
118
115
108
90
87
81
74
57
52
50
44
43
42
34

Category

75
47
31
25
6
5
2
2
2
1
1

Keyword

58
41
30
19
18
16
15
15
14
13
13
12
12
11
11
10
10
10
9
9

Journal

14
13
11
5
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2

NCATS Publications

Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.


Papaleo F, Yang F, Paterson C, Palumbo S, Carr GV, Wang Y, Floyd K, Huang W, Thomas C, Chen J, Weinberger DR, Law AJ


J. Neurosci. , (36), 4859-75, 2016.

Article Pubmed

Sample image from publication page

Ranking Differential Drug Activities from Dose-Response Synthetic Lethality Screens.


Guha R, Mathews Griner LA, Keller JM, Zhang X, Fitzgerald D, Antignani A, Pastan I, Thomas C, Ferrer-Alegre M


J Biomol Screen , 2016.

Article Pubmed

Sample image from publication page

RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.


Baranello L, Wojtowicz D, Cui K, Devaiah BN, Chung HJ, Chan-Salis KY, Guha R, Wilson K, Zhang X, Zhang H, Piotrowski J, Thomas C, Singer DS, Pugh BF, Pommier Y, Przytycka TM, Kouzine F, Lewis BA, Zhao K, Levens D


Cell , (165), 357-71, 2016.

Article Pubmed

Sample image from publication page

Structure Property Relationships of Carboxylic Acid Isosteres.


Lassalas P, Gay B, Lasfargeas C, James MJ, Tran V, Vijayendran KG, Brunden KR, Kozlowski MC, Thomas C, Smith AB, Huryn DM, Ballatore C


J. Med. Chem. , (59), 3183-203, 2016.

Article Pubmed

Sample image from publication page

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.


Smith SJ, Pauly GT, Akram A, Melody K, Rai Bantukallu G, Maloney DJ, Ambrose Z, Thomas C, Schneider JT, Hughes SH


Retrovirology , (13), 11, 2016.

Article Pubmed

Sample image from publication page

Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.


Ju W, Zhang M, Wilson K, Petrus MN, Bamford RN, Zhang X, Guha R, Ferrer-Alegre M, Thomas C, Waldmann TA


Proc. Natl. Acad. Sci. U.S.A. , (113), 1624-9, 2016.

Article Pubmed

Sample image from publication page

Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1.


Ali-Rahmani F, FitzGerald DJ, Martin S, Patel P, Prunotto M, Ormanoglu P, Thomas C, Pastan I


Cancer Res. , (76), 1560-8, 2016.

Article Pubmed

A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome.


Doyle JJ, Doyle AJ, Wilson NK, Habashi JP, Bedja D, Whitworth RE, Lindsay ME, Schoenhoff F, Myers L, Huso N, Bachir S, Squires O, Rusholme B, Ehsan H, Huso D, Thomas C, Caulfield MJ, Van Eyk JE, Judge DP, Dietz HC, GenTAC Registry Consortium , MIBAVA Leducq Consortium


Elife , (4), 2015.

Article Pubmed

Sample image from publication page

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.


Bogen D, Wei JS, Azorsa DO, Ormanoglu P, Buehler E, Guha R, Keller JM, Mathews Griner LA, Ferrer-Alegre M, Song YK, Liao H, Mendoza A, Gryder BE, Sindri S, He J, Wen X, Zhang S, Shern JF, Yohe ME, Taschner-Mandl S, Shohet JM, Thomas C, Martin SE, Ambros PF, Khan J


Oncotarget , (6), 35247-62, 2015.

Article Pubmed

High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations.


Mott BT, Eastman R, Guha R, Sherlach KS, Siriwardana A, Shinn P, McKnight C, Michael S, Lacerda-Queiroz N, Patel PR, Khine P, Sun H, Kasbekar M, Aghdam N, Fontaine SD, Liu D, Mierzwa T, Mathews-Griner LA, Ferrer-Alegre M, Renslo AR, Inglese J, Yuan J, Roepe PD, Su XZ, Thomas C


Sci Rep , (5), 13891, 2015.

Article Pubmed

Sample image from publication page